XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.26.1

Goodwill and other intangible assets | 6 Months Ended
--- | ---
Jun. 30, 2026
Intangible assets and goodwill [abstract] |
Goodwill and other intangible assets | B.3. Goodwill and other intangible assets Goodwill amounted to €41,954 million as of June 30, 2026, versus €41,300 million as of December 31, 2025. The movement during the period reflects the impact of changes in exchange rates and the recognition of the goodwill arising on the Dynavax acquisition (see note B.1.1.), partially offset by the reclassification of the goodwill relating to the Brazilian generics business to Assets held for sale as a result of the proposed divestment (see note B.1.2.). Movements in other intangible assets during the first half of 2026 were as follows:
(€ million) | Acquired R&D | Products, trademarks and other rights | Software | Total other intangible assets
Gross value at January 1, 2026 | 14,951 |  | 66,746 |  | 1,888 |  | 83,585 |
Changes in scope of consolidation (a) | — |  | 1,149 |  | 1 |  | 1,150 |
Acquisitions and other increases | 321 |  | 122 |  | 88 |  | 531 |
Disposals and other decreases | (534) |  | (17) |  | (28) |  | (579) |
Currency translation differences | 324 |  | 1,232 |  | 12 |  | 1,568 |
Transfers (b) | (245) |  | (162) |  | (4) |  | (411) |
Gross value at June 30, 2026 | 14,817 |  | 69,070 |  | 1,957 |  | 85,844 |
Accumulated amortization and impairment at January 1, 2026 | (6,220) |  | (49,624) |  | (1,480) |  | (57,324) |
Amortization expense | — |  | (1,106) |  | (58) |  | (1,164) |
Impairment losses, net of reversals (c) | (970) |  | (61) |  | (17) |  | (1,048) |
Disposals and other decreases | 534 |  | 17 |  | 26 |  | 577 |
Currency translation differences | (135) |  | (785) |  | (10) |  | (930) |
Transfers (b) | — |  | 400 |  | 4 |  | 404 |
Accumulated amortization and impairment at June 30, 2026 | (6,791) |  | (51,159) |  | (1,535) |  | (59,485) |
Carrying amount at January 1, 2026 | 8,731 |  | 17,122 |  | 408 |  | 26,261 |
Carrying amount at June 30, 2026 | 8,026 |  | 17,911 |  | 422 |  | 26,359 |
(a)The “Changes in scope of consolidation” line mainly comprises the intangible assets recognized as part of the Dynavax acquisition (see Note B.1.) (b)The “Transfers” line mainly comprises (i) acquired R&D that came into commercial use during the period and (ii) reclassifications of assets to Assets held for sale. (c)See Note B.4. “Products, trademarks and other products” mainly comprise: •marketed products, with a carrying amount of €17.1 bil lion as of June 30, 2026 (versus €16.2 billion as of December 31, 2025) and a weighted average amortization period of approximately 11 years; and •technological platforms brought into service, with a carrying amou nt of €0.8 billion as of June 30, 2026 (versus €0.9 billion as of December 31, 2025) and a weighted average amortization period of approximately 18 years.

X
- Definition The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_IntangibleAssetsAndGoodwillAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration